Latest news:
New publication: ZTX® in vivo data contribute to the preclinical evaluation of Telomir-Zn in triple-negative breast cancer
Read more
Contact
Contact
Category:

BioReperia

Explore our latest news articles on how our contract research organization accelerates pre-clinical drug development.

Read article

Read article

BioReperia Announces New Leadership Appointments

/
BioReperia
Pressrelease

Read article

BioReperia represented at Tumor Models Nordics

/
BioReperia
Conferences and meetings

Read article

New R&D project

/
Awards and reportages
BioReperia

Read article

BioReperia is now in Switzerland!

/
BioReperia
BioReperia hiring!

Read article

We are hiring!

/
BioReperia

This website uses cookies

We use essential cookies to make our website work. With your consent, we also use non-essential cookies to improve the user experience and analyze website traffic. You can change your cookie settings at any time by clicking on Cookie settings..

Which cookies do you want to accept?

This website uses cookies

We use different types of cookies to optimize your experience on our website. Click on the categories below to learn more about their purposes. You can choose which types of cookies to allow and can change your settings at any time. Remember that disabling cookies may affect your experience on the website.

Which cookies do you want to accept?

These cookies are essential for the proper functioning of the website and cannot be disabled.

  • Google Analytics (anonymized)

These cookies collect information about how you use our website. All of the data is anonymized and cannot be used to identify you.

  • Google Analytics
Read more about Google's privacy policy and terms of use